While the United Nations Environment Programme (UNEP) had...
Category:
Health
Latest
Class action lawsuits pile up over UnitedHealth data breach
Plaintiffs say that information stored by Change, and now...
PIA bars pilots and cabin crew from fasting during Ramzan while on duty
The Pakistan International Airlines' (PIA) order has come in the...
India plans 50% increase in oxygen production before third Covid wave
While demand for medical oxygen in India has considerably reduced since the peak, reaching near pre-COVID levels, gas companies along with the government are gearing up for a scenario where the third wave could be worse than the previous one.
Brazil bans China’s Sinovac Covid vax over fears of contamination
Anvisa, the regulator, suspended Sinovac for a period of three months after learning that vials containing the shots were filled at an unauthorised production base, the Washington Post reported. The matter is being investigated.
12-year-old dies of Nipah in Kerala; 2 health workers show symptoms says health min
Two more people have been identified with symptoms of Nipah virus infection, Kerala health minister Veen George said here on Sunday.
The two are among the 20 high risk contacts of the deceased 12-year-old child, she said.
The Kozhikode Medical college hospital sources told PTI that they have since opened an exclusive Nipah ward to cater to any possible outbreak of the virus.
Govt determined to vaccinate everyone by December this year: Union Minister Kishan Reddy
”We want to reach out to the last person to be vaccinated in the country, in the most remotest part by December this year. It is also a matter of great pride that India was one of the two countries which invented a vaccine for COVID, besides USA, this raised the stature of Indian scientists and the country in the world,” the release quoted Kishan Reddy as saying.
”As many as 153 countries have sought our vaccines and some even paid the respective companies advance amount, but the government placed an embargo on export till people in our country are vaccinated,” he said.
Study suggests Delta does not cause more severe childhood Covid
The paper by the Centers for Disease Control and Prevention also found that between June 20 and July 31, 2021, unvaccinated adolescents were more than 10 times more likely to be hospitalized than those who were vaccinated.
One in every two families paid over Rs 750 for COVID antibody test in India: Survey
According to the survey, 29 per cent of the respondents said they paid Rs 1,000 or more during their COVID antibody test. Further, 21 per cent said they paid between Rs 750-1000 and 14 per cent said they paid between Rs 500-750.
While, 24 per cent said they paid Rs 250-500 and 7 per cent said they paid less than Rs 250. 5 per cent respondents did not say anything. “On an aggregate basis, 50 per cent of citizens who got a COVID antibody test done paid over Rs 750 for it,” said LocalCircles release.
FSSAI asks e-tailers to delist non-dairy products claiming as dairy items
”Since a lot of such products are sold through e-commerce Food Business Operators (FBOs), FSSAI has instructed all e-commerce platforms to delist such products, which are reported to be in contravention to the regulatory provisions related to the application of dairy ‘terms’ from their online platforms, immediately,” it said.
The FSSAI has further directed that no such defaulting products listed on the online platforms are allowed for sale in the future as well.
Govt revises NLEM: Slashes prices of 39 commonly used medicines
The commonly used drugs, which were brought under the price cap includes Teneligliptin — an anti diabetes drug, popular anti-TB drugs, Ivermectin — used in Covid treatment, Rotavirus vaccine, among others.
India in need of 4.3 million more nurses by 2024 to meet WHO norms
With 1.7 nurses per 1,000 population, India falls short of the WHO recommended rate of 3 nurses per 1,000 population, they said, noting that the country is in need of 4.3 million more nurses by 2024 to meet WHO norms.
Covid-19 jabs effective at reducing severe illness, hospitalisation: Lancet
They found that of more than 1.2 million adults who received at least one dose of either the Pfizer-BioNTech, Oxford-AstraZeneca, or Moderna vaccine, fewer than 0.5 per cent reported a breakthrough infection over 14 days after their first dose.
People most vulnerable to a breakthrough infection after their first vaccine dose included frail older adults, 60 years and older, and those living with underlying conditions such as obesity, heart disease, kidney disease, and lung disease, they said.